Relevant bibliographies by topics / Clostidium botulinum type E

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Clostidium botulinum type E'

Author: Grafiati
Published: 4 June 2021
Last updated: 7 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Clostidium botulinum type E.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Clostidium botulinum type E"

1

Eleopra, Roberto, Valeria Tugnoli, Rocco Quatrale, Ornella Rossetto, Cesare Montecucco, and Dirk Dressler. "Clinical use of non-a botulinum toxins: Botulinum toxin type C and botulinum toxin type F." Neurotoxicity Research 9, no. 2-3 (2006): 127–31. http://dx.doi.org/10.1007/bf03033930.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Delgado, Mauricio R. "Botulinum Neurotoxin Type A." Journal of the American Academy of Orthopaedic Surgeons 11, no. 5 (2003): 291–94. http://dx.doi.org/10.5435/00124635-200309000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dalton, Jo. "Botulinum toxin type A." Inpharma Weekly &NA;, no. 1211 (1999): 11–12. http://dx.doi.org/10.2165/00128413-199912110-00024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sadick, Neil S. "Botulinum Toxin Type B." Dermatologic Surgery 29, no. 4 (2003): 348–51. http://dx.doi.org/10.1046/j.1524-4725.2002.29083.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Alouf, Erin, Tina Murphy, and Gregory Alouf. "Botulinum Toxin Type A." Plastic Surgical Nursing 38, no. 3 (2018): 105–13. http://dx.doi.org/10.1097/psn.0000000000000236.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Alouf, Erin, Tina Murphy, and Gregory Alouf. "Botulinum Toxin Type A." Plastic Surgical Nursing 39, no. 4 (2019): 148–56. http://dx.doi.org/10.1097/psn.0000000000000287.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

KONTOCHRISTOPOULOS, GEORGE, ATHINA N. KATSAVOU, OLGA KALOGIROU, STELIOS AGELIDIS, and NIKOLETA ZAKOPOULOU. "Botulinum Toxin Type A." Dermatologic Surgery 33, no. 7 (2007): 882–83. http://dx.doi.org/10.1097/00042728-200707000-00020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

SADICK, NEIL S. "Botulinum Toxin Type B." Dermatologic Surgery 29, no. 4 (2003): 348–51. http://dx.doi.org/10.1097/00042728-200304000-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lowe, Philippa L., and Nicholas J. Lowe. "Botulinum Toxin Type B." Dermatologic Surgery 40, no. 12 (2014): 1328–33. http://dx.doi.org/10.1097/dss.0000000000000178.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Miller, Jared, and Earl Clarkson. "Botulinum Toxin Type A." Dental Clinics of North America 60, no. 2 (2016): 509–21. http://dx.doi.org/10.1016/j.cden.2015.11.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Clostidium botulinum type E"

1

Davis, Tom Owen. "Regulation of botulinum toxin complex formation in Clostridium botulinum : type A NCTC 2916." Thesis, Open University, 1998. http://oro.open.ac.uk/57744/.

Full text
Abstract:
Genomic DNA fragments encoding the silent type B neurotoxin gene from Clostridium botulinum NCTC 2916 have been cloned and the complete nucleotide sequence determined. The translated sequence revealed that the gene encoded a neurotoxin which was closely related to type B neurotoxin genes from Group I Clostridium botulinum. However among the nucleotide sequence differences, aG to T transition has interrupted the coding sequence with the formation of a stop codon. In addition the deletion of an adenine residue has resulted in a frame-shift mutation. Analysis of the DNA sequence contiguous with t
APA, Harvard, Vancouver, ISO, and other styles
2

Bucknavage, Martin M. "Growth and survival of Clostridium botulinum type E in pasturized oysters." Thesis, This resource online, 1988. http://scholar.lib.vt.edu/theses/available/etd-04122010-083636/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cadieux, Brigitte. "Development of a novel, rapid, in vitro assay for the detection of Clostridium botulinum neurotoxin type E." Thesis, McGill University, 2001. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=32836.

Full text
Abstract:
Botulism is a foodborne intoxication caused by ingestion of Clostridium botulinum neurotoxin (BoNT). Preliminary studies focussed on the production of polyclonal antisera against BoNT/E by immunizing a rabbit with botulinal toxoid type E. The antiserum was subsequently used to detect BoNT/E using the slot blot immunoassay where samples were applied to a slot blot filtration manifold and drawn by vacuum through a membrane. The membrane was then immunologically processed before chemiluminescent detection. However, the antisera lacked specificity and cross-reacted with closely related clostridia
APA, Harvard, Vancouver, ISO, and other styles
4

Sharkey, Freddie. "Toxin gene expression in Clostridium botulinum type E under different growth conditions." Thesis, University of Ulster, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.274025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hunter, Leonie C. "The role of Clostridium botulinum type C in the pathogenesis of equine grass sickness." Thesis, University of Edinburgh, 2001. http://hdl.handle.net/1842/24726.

Full text
Abstract:
This thesis investigates the hypothesis that EGS is caused by a toxicoinfection with <i>C. botulinum</i> type C, where the organism grows and produces toxin in the gastrointestinal tract (GI). The study has taken three main directions: 1) detection of the botulinum type C neurotoxin (BoNT/C) in the GI tract of horses with and without EGS. 2) isolation and characterisation of organisms phenotypically resembling<i> C. botulinum</i> type C, and 3) detection of antibodies to the type C neurotoxin and surface antigens in the serum, GI tract, colostrum and milk. BoNT/C was detected by ELISA both dir
APA, Harvard, Vancouver, ISO, and other styles
6

Pimentel, Leonardo Halley Carvalho. "Different doses of botulinum toxin in spastic equinus foot of poststroke patients." Universidade Federal do CearÃ, 2013. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=11077.

Full text
Abstract:
nÃo hÃ<br>Background: Botulinum toxin type A (BTX-A), one of the most potent biological toxins, acts by blocking neuromuscular transmission via inhibiting acetylcholine release and is a well-known treatment for poststroke spasticity, despite some variations among dose protocols. Spasticity is one of the factors that affect the functional rehabilitation process in stroke. Spasticity arises from the loss of myotatic reflex inhibition, resulting from upper motor neuron lesion. Equinus foot is common in lower limb spasticity after stroke worsening gait pattern and functional independence. The obj
APA, Harvard, Vancouver, ISO, and other styles
7

Whitney, Patrick F. "Patient Reported Efficacy of Botulinum Toxin Type A in the Treatment of Chronic Migraine Headaches." Scholar Commons, 2010. https://scholarcommons.usf.edu/etd/1806.

Full text
Abstract:
Objective: To assess patient reported efficacy of Botulinum toxin type-A for the prophylaxis of migraine headaches in patients with frequent migraine headaches prior to initiation of treatment with Botulinum toxin type-A compared to post treatment. Questions addressed include is there a difference in frequency of migraine headaches following treatment with Botulinum toxin type-A, is there a difference in cost of conventional treatment versus Botulinum toxin type-A and is there a difference in quality of life. Research Plan: Questions addressed patient status prior to the initiation of treatmen
APA, Harvard, Vancouver, ISO, and other styles
8

Morineaux, Valérie. "Identification et Quantification des Sous-Types de la Neurotoxine Botulique de Type A par Spectrométrie de Masse." Thesis, Paris 11, 2015. http://www.theses.fr/2015PA114826.

Full text
Abstract:
Les toxines botuliques (BoNTs) sont les substances les plus toxiques connues. Elles sont responsables du botulisme, une maladie rare mais le plus souvent mortelle sans prise en charge médicale. Cependant, les applications médicales des BoNTs sont de plus en plus nombreuses du fait de leurs propriétés paralysantes. Leur toxicité par voie inhalée en fait un des 6 principaux agents du risque intentionnel. Les BoNTs, produites par Clostridium botulinum, se répartissent en 7 types sérologiques qui se déclinent en sous-types. Cette biodiversité rend difficile leur identification par les méthodes cla
APA, Harvard, Vancouver, ISO, and other styles
9

Karlberg, Therese. "Patienters upplevelse av smärtlindring och livskvalitet efter botoxbehandling i smärtlindrande syfte : En intervjustudie." Thesis, Uppsala universitet, Institutionen för folkhälso- och vårdvetenskap, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-144458.

Full text
Abstract:
Syftet med studien var att undersöka patienters upplevelse av smärtlindring och livskvalitet efter botoxbehandling i smärtlindrande syfte samt patienternas inställning till Botox. Metod: En kvalitativ intervjustudie med en deskriptiv och explorativ design. Urvalet bestod av sju patienter, sex kvinnor och en man, vilka behandlas men botoxbehandling vid Smärtcentrum på Akademiska sjukhuset i Uppsala. Resultat: Materialet analyserades enligt syftet under tre kategorier: smärtlindring, oro/nedstämdhet samt inställning till Botox. Samtliga informanter har fått en minskad smärta till följd av botoxb
APA, Harvard, Vancouver, ISO, and other styles
10

Flemban, Abeer. "Does combining physiotherapy with Botulinum toxin type A injections improve the management of children with spastic cerebral palsy?" Thesis, University of Glasgow, 2008. http://theses.gla.ac.uk/494/.

Full text
Abstract:
Cerebral palsy (CP) affects around every one in 500 children born. It isn’t a particular illness or disease, but an umbrella term used to describe a physical condition that affects movement as a result of injury to the brain. There are several types of CP, the main ones being spastic, athetoid and ataxic. Despite medical advances, there is no cure for CP but there are ranges of treatments from drugs to Botulinum toxin type A injections, massage therapy to surgery. The aim of this study is to look at two of these treatments, namely Botulinum toxin type A injections and physiotherapy to treat sp
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Clostidium botulinum type E"

1

Moriarty, Kate Coleman. Botulinum toxin in facial rejuvenation. Mosby, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Benedetto, Anthony V. Botulinum toxins in clinical aesthetic practice. 2nd ed. Informa Healthcare, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Botulinum toxins in clinical aesthetic practice. 2nd ed. Informa Healthcare, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

K, Gadre Arun, Muller Chris MD, and American Academy of Otolaryngology--Head and Neck Surgery Foundation., eds. Botulinum toxin in otolaryngology: A practical guide. American Academy of Otolaryngology--Head and Neck Surgery Foundation, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sharkey, Freddie. Toxin gene expression in clostridium botulinum type E under different growth conditions. The author], 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sharkey, Freddie. Toxin gene expression in clostridium botulinum type E under different growth conditions. The author], 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sharkey, Freddie. Toxin gene expression in clostridium botulinum type E under different growth conditions. The author], 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Dover, Jeffrey S., Jean Carruthers, Alastair Carruthers, and Murad Alam. Botulinum Toxin. Elsevier - Health Sciences Division, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Alastair, Carruthers, and Carruthers Jean, eds. Botulinum toxin: Cosmetic and medical uses. Elsevier Saunders, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Coleman-Moriarty, Kate. Botulinum Toxin in Facial Rejuvenation. Mosby, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Clostidium botulinum type E"

1

Bilu Martin, Donna, and Stephen Mandy. "Exciting New Uses of Botulinum Toxin Type A: Dermatology/Dermatologic Surgery and Beyond." In Botulinum Toxins. John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781118661833.ch25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Stevens, Raymond C. "Low Resolution Model of Botulinum Neurotoxin Type A." In Botulinum and Tetanus Neurotoxins. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4757-9542-4_42.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Greene, Paul, and Stanley Fahn. "Development of Antibodies to Botulinum Toxin Type A in Patients with Torticollis Treated with Injections of Botulinum Toxin Type A." In Botulinum and Tetanus Neurotoxins. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4757-9542-4_72.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hallis, Bassam, Sarah Fooks, Clifford Shone, and Peter Hambleton. "Characterization of Monoclonal Antibodies to Botulinum Type A Neurotoxin." In Botulinum and Tetanus Neurotoxins. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4757-9542-4_47.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Thalley, B. S., M. B. van Boldrik, S. B. Carroll, W. Tepp, B. R. DasGupta, and D. C. Stafford. "Development of an Avian Antitoxin to Type A Botulinum Neurotoxin." In Botulinum and Tetanus Neurotoxins. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4757-9542-4_51.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chan, Woon Ling, Dorothea Sesardic, and Clifford C. Shone. "Proliferative T Cell Response to Botulinum Toxin Type A in Mice." In Botulinum and Tetanus Neurotoxins. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4757-9542-4_37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nukina, Masafumi, Yumi Mochida, Tsutomu Miyata, Sumiko Sakaguchi, and Genji Sakaguchi. "Purification, Characterization, and Oral Toxicity of Botulinum Type G Progenitor Toxin." In Botulinum and Tetanus Neurotoxins. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4757-9542-4_44.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Moyer, E. D., E. A. Stephens, F. Esch, M. Litwak, and J. Arezzo. "Effects of Intramuscular Injection of Botulinum Toxin Type B in Nonhuman Primates." In Botulinum and Tetanus Neurotoxins. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4757-9542-4_73.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rollnik, J. D., and R. Dengler. "Botulinum Toxin (DYSPORT) in Tension-Type Headaches." In Functional Rehabilitation in Neurosurgery and Neurotraumatology. Springer Vienna, 2002. http://dx.doi.org/10.1007/978-3-7091-6105-0_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Yokosawa, Noriko, Kouichi Kimura, Kayo Tsuzuki, Nobuhiro Fujii, Bunei Syuto, and Keiji Oguma. "Inhibition of Norepinephrine Secretion from Digitonin Permeabilized PC12 Cells by C. Botulinum Type D Toxin." In Botulinum and Tetanus Neurotoxins. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4757-9542-4_34.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Clostidium botulinum type E"

1

Wu, Xiudong, Chensha Li, Xuezhen Huang, et al. "A microfluidic sensor of Botulinum neurotoxin type a utilizing SNAP-25 incorporated responsive hydrogel." In 2013 IEEE Sensors. IEEE, 2013. http://dx.doi.org/10.1109/icsens.2013.6688282.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ramos, J. Cordero, MD Alvarado Fernández, S. Santana Martínez, M. Murillo Izquierdo, and MD Guerrero Aznar. "DI-094 Botulinum toxin type a for the treatment of neurological diseases: drug utilisation review." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.341.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Taylor, Graham, Donald Leo, and Andy Sarles. "Detection of Botulinum Neurotoxin/A Insertion Using an Encapsulated Interface Bilayer." In ASME 2012 Conference on Smart Materials, Adaptive Structures and Intelligent Systems. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/smasis2012-8101.

Full text
Abstract:
Many signaling mechanisms in living cells occur at biological boundaries via cell surface receptors and membrane proteins embedded in lipid bilayers. The coordination of actions of sensory and motor neurons in the nervous system represents one example of many that heavily depends on lipid membrane bound receptor mediated signaling. As a result, chemical and biological toxins that disrupt these neural signals can have severe physiological effects, including paralysis and death. Botulinum neurotoxin Type A (BoNT/A) is a proteolytic toxin that inserts through vesicle membranes and cleaves membran
APA, Harvard, Vancouver, ISO, and other styles
4

Guyot, P., C. Kalyvas, L. Weijers, A. Karabis, and N. Danchenko. "IP 467. Botulinum Toxin Type A in the Management of Spasticity in Children—A Systematic Literature Review and Bayesian Network Meta-analysis." In Abstracts of the 44th Annual Meeting of the Society for Neuropediatrics. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1676031.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Clostidium botulinum type E"

1

Furey, William, Martin Sax, and S. Swaminathan. X-Ray Crystallography of Botulinum Neurotoxin Type E and Its Functional Subunits. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada413858.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cairo, Jessica, Iulia Gherman, and Paul Cook. The effects of consumer freezing of food on its use-by date. Food Standards Agency, 2021. http://dx.doi.org/10.46756/sci.fsa.ret874.

Full text
Abstract:
The current Food Standards Agency consumer guidance states that consumers can freeze pre-packed food right up to the “use-by” date and, once food has been defrosted, it should be consumed within 24 hours. This strategic review has collated relevant data to determine whether there is an increased risk in relation to freezing ready-to-eat and non-ready-to-eat foods on the use-by date compared to the day before the use-by date. The review has focused on how the shelf-life of a food is determined and the effects of freezing, thawing and refrigeration on foodborne pathogens, including Bacillus spp.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Clostidium botulinum type E' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography